Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Nov 13, 2009 sing george l Director Buy 2,500 18.68 - 18.72
May 18, 2010 sing george l Director Buy 5,000 28.44
May 18, 2010 sing george l Director Buy 2,500 28.64
Nov 13, 2009 sing george l Director Buy 10,000 18.78
Nov 18, 2015 sing george l Director Option Execute 3,000 19.69
May 27, 2015 sing george l Director Option Execute 5,000 19.69
Nov 26, 2013 sing george l Director Option Execute 10,000 15.01
Feb 21, 2014 sing george l Director Option Execute 15,000 15.80
Feb 14, 2014 sing george l Director Option Execute 15,000 9.17
Feb 20, 2015 sing george l Director Option Execute 15,000 18.61
May 10, 2013 sing george l Director Option Execute 5,000 15.01
Aug 22, 2012 sing george l Director Option Execute 5,000 18.80
Aug 23, 2012 sing george l Director Option Execute 5,000 18.80
Jul 26, 2012 sing george l Director Option Execute 5,000 18.80
Jun 9, 2010 sing george l Director Option Execute 5,000 25.43
Nov 22, 2011 sing george l Director Option Execute 15,000 28.81
May 6, 2013 tessier-lavigne marc Director Option Execute 13,334 50.91 - 57.11
Feb 26, 2015 tessier-lavigne marc Director Option Execute 3,000 50.91
Aug 26, 2014 tessier-lavigne marc Director Option Execute 1,387 50.91
Aug 27, 2014 tessier-lavigne marc Director Option Execute 3,000 50.91
Showing 361-380 of 1036 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)